Marc Cote is an entrepreneur, a business/executive coach and area representative with FocalPoint Business Coaching. Marc is also a former corporate executive and leverages his coaching program materials and his 30 years of business experience to help entrepreneur, business leaders and executives raise money, improve their effectiveness, develop their people and enhance the performance of their teams and companies. Marc is the son of a second-generation business owner with a deep-seated passion for business and helping others succeed. He was also a co-founder and the COO of Accellient Partners LLC, a drug development consulting firm, Synchroneuron Inc, a venture-backed biotech where he helped raise over $25M and Ternus Pharma, Inc, a seed-stage start-up pharma company. Marc continues to focus much of his coaching practice supporting those in the life sciences arena. Marc was also previously the COO of Aptuit Consulting, a global biotech practice where he was responsible for managing all operating, financial & business development activities. Prior to Aptuit, Marc was with Dunkin’ Brands and had vice president roles across multiple functions. Marc started his career in the Entrepreneurial Services Group at EY, he received a BS in Accountancy from Bentley College, summa cum laude, and earned his CPA certificate in MA where he was a licensed CPA for 17 years Marc is a member of Boston Harbor Angels and Sky Ventures where he is an active investor and also maintains a Board role on select portfolio companies. Marc is also a Co-Chair of Mass Bio's Entrepreneur University and the Boston Chapter of The Financial Executives Networking Group.

Jennifer J. Davagian is the Chief Executive Officer, President and Chairperson of the Board of Managers. Ms. Davagian has 20+ years experience assembling teams of individuals to build businesses from conception to commercialization. As an IBD patient, Jennifer knows the daily struggles of patients and compliance decisions facing healthcare outcomes. As a business woman in the area of Science, Technology and Manufacturing, she has a keen understanding of new medical technology development, regulatory submissions and GMP compliance, in addition to new product commercial execution. Ms. Davagian teaches at Boston University School of Management on a variety of business topics. She has written for both the National Institute of Health and the Food and Drug Administration.

John Hession is a Partner at Morse, Barnes-Brown & Pendleton, and a member of the firm’s Corporate, Venture Capital and Life Sciences practice groups. Previously, John was a co-founder of Cooley LLP's Boston office, and served as the Managing Partner of the Cooley Boston office for its first several years of operation, helping to steer and grow the Boston office from ten to seventy-plus professionals and staff. For the last thirty-five years, John has represented emerging-growth companies, as both a legal and business advisor, principally in the life sciences, medical device, hardware, software and software services sectors, as well as angels and venture capital funds in the investment process. John is also angel investor in emerging companies. John’s practice includes both start-up, emerging growth and later-stage company work, where he serves as outside general counsel. This work includes corporate governance; equity-based compensation strategies; mergers and acquisitions (representing buyers and sellers); and strategic alliances, corporate partnering, joint ventures, collaboration and development projects, and other strategic alliances involving technology transfers; as well venture capital and angel financings of companies in these sectors, representing principally companies and their management teams. John has structured and negotiated more than 400 debt and equity financings, ranging in scale from $500,000 to $250 million, and more than 350 acquisitions ranging in size from $1.0 million to $4.2 billion. During his thirty-five year career, John has represented more than 400 companies from the earliest stages of development, from cradle to culmination, from inception to liquidity (including public offering and acquisitions). John has won a number of industry awards during his career, including Best Lawyers in America, IP Stars (Managing Intellectual Property), Lawdragon 500 Leading Deal Makers, a Massachusetts Super Lawyer, and Best Lawyers in New England.

Jill is responsible for ensuring operational excellence throughout the company. In this position, she oversees iSpecimen’s supply partner programs and operations, human resources, marketing, corporate communications, and corporate strategy. She is also responsible for ensuring regulatory compliance, privacy and security across the company’s operations. Jill has over 25 years of experience in operational management, strategy, and marketing. Before joining iSpecimen, Jill ran a consulting business to help companies develop business and product strategies, raise funds, create brands, and launch new products. Prior to that, Jill was on the founding team and Director of Marketing at Storigen Systems, where she built and ran the company’s marketing organization, developed the company’s brand identity, and launched several successful products. She was also the Director of Product Marketing and Management at Avid Technology, managing the P&L for Avid’s $400M editing product line. Jill graduated with distinction from Cornell University with a BS in electrical engineering and received her MBA from Stanford University.